Innate Pharma SA Travel Expense
Innate Pharma SA (IPHA) reported Travel Expense of EUR 748.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:TravelExpense · last filed 2026-04-01
| Period end | Travel Expense 6 month | Travel Expense 12 month | Travel Expense 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | 748.00K EUR 20-F · filed 2026-04-01 | ||
| 2025-06-30 | 407.00K EUR 6-K · filed 2025-09-17 | ||
| 2024-12-31 | 776.00K EUR 20-F · filed 2026-04-01 | ||
| 2024-06-30 | 423.00K EUR 6-K · filed 2025-09-17 | ||
| 2023-12-31 | 648.00K EUR 20-F · filed 2026-04-01 | ||
| 2023-06-30 | 323.00K EUR 6-K · filed 2024-09-12 | ||
| 2022-12-31 | 718.00K EUR 20-F · filed 2025-04-30 | ||
| 2022-06-30 | 354.00K EUR 6-K · filed 2023-09-14 | ||
| 2021-12-31 | 273.00K EUR 20-F · filed 2024-04-04 | ||
| 2021-06-30 | 58.00K EUR 6-K · filed 2022-09-15 | ||
| 2020-12-31 | 284.00K EUR 20-F · filed 2023-04-06 | 839.00K EUR 20-F · filed 2021-04-27 | |
| 2020-06-30 | 273.00K EUR 6-K · filed 2021-09-15 | ||
| 2019-12-31 | 1.43M EUR 20-F · filed 2022-04-04 | 1.75M EUR 20-F · filed 2020-04-24 | |
| 2018-12-31 | 992.00K EUR 20-F · filed 2021-04-27 | ||
| 2017-12-31 | 1.29M EUR 20-F · filed 2020-04-24 |